Source: ALL
Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 5770
Gene Symbol: PTPN1
PTPN1 		0.300 Biomarker disease CTD_human Recurrent somatic mutations of PTPN1 in primary mediastinal B cell lymphoma and Hodgkin lymphoma. 24531327 2014
Entrez Id: 10797
Gene Symbol: MTHFD2
MTHFD2 		0.300 Biomarker disease CTD_human KRAS mutation status is associated with enhanced dependency on folate metabolism pathways in non-small cell lung cancer cells. 24688052 2014
Entrez Id: 5966
Gene Symbol: REL
REL 		0.300 Biomarker disease CTD_human A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3). 21037568 2010
Entrez Id: 2625
Gene Symbol: GATA3
GATA3 		0.300 Biomarker disease CTD_human A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3). 21037568 2010
Entrez Id: 5820
Gene Symbol: PVT1
PVT1 		0.300 Biomarker disease CTD_human A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3). 21037568 2010
Entrez Id: 54658
Gene Symbol: UGT1A1
UGT1A1 		0.300 Biomarker disease CTD_human Pharmacogenetic study in Hodgkin lymphomas reveals the impact of UGT1A1 polymorphisms on patient prognosis. 18768784 2009
Entrez Id: 4792
Gene Symbol: NFKBIA
NFKBIA 		0.300 Biomarker disease CTD_human Polymorphic variation in NFKB1 and other aspirin-related genes and risk of Hodgkin lymphoma. 19223558 2009
Entrez Id: 8837
Gene Symbol: CFLAR
CFLAR 		0.300 Biomarker disease CTD_human Bortezomib induces caspase-dependent apoptosis in Hodgkin lymphoma cell lines and is associated with reduced c-FLIP expression: a gene expression profiling study with implications for potential combination therapies. 17659339 2008
Entrez Id: 1440
Gene Symbol: CSF3
CSF3 		0.300 Therapeutic disease CTD_human Hodgkin lymphoma among patients infected with HIV in post-HAART era. 17562247 2007
Entrez Id: 943
Gene Symbol: TNFRSF8
TNFRSF8 		0.300 Biomarker disease CTD_human Very high levels of soluble CD30 recognize the patients with classical Hodgkin's lymphoma retaining a very poor prognosis. 16879607 2006
Entrez Id: 3440
Gene Symbol: IFNA2
IFNA2 		0.300 Therapeutic disease CTD_human Dacarbazine, cisplatin, and interferon-alfa-2b with or without interleukin-2 in metastatic melanoma: a randomized phase III trial (18951) of the European Organisation for Research and Treatment of Cancer Melanoma Group. 16170182 2005
Entrez Id: 943
Gene Symbol: TNFRSF8
TNFRSF8 		0.300 Biomarker disease CTD_human Serum levels of soluble CD30 improve International Prognostic Score in predicting the outcome of advanced Hodgkin's lymphoma. 12453859 2002
Entrez Id: 2950
Gene Symbol: GSTP1
GSTP1 		0.300 Biomarker disease CTD_human Genetic polymorphisms of biotransformation enzymes in patients with Hodgkin's and non-Hodgkin's lymphomas. 11406608 2001
Entrez Id: 200942
Gene Symbol: KLHDC8B
KLHDC8B 		0.300 Biomarker disease CTD_human
Entrez Id: 10665
Gene Symbol: TSBP1
TSBP1 		0.100 GeneticVariation disease GWASCAT Genome-wide association study of classical Hodgkin lymphoma identifies key regulators of disease susceptibility. 29196614 2017
Entrez Id: 285830
Gene Symbol: HLA-F-AS1
HLA-F-AS1 		0.100 GeneticVariation disease GWASCAT Genome-wide association study of classical Hodgkin lymphoma identifies key regulators of disease susceptibility. 29196614 2017
Entrez Id: 101929163
Gene Symbol: TSBP1-AS1
TSBP1-AS1 		0.100 GeneticVariation disease GWASCAT Genome-wide association study of classical Hodgkin lymphoma identifies key regulators of disease susceptibility. 29196614 2017
Entrez Id: 3115
Gene Symbol: HLA-DPB1
HLA-DPB1 		0.010 GeneticVariation disease BEFREE Additionally, independent loci within the HLA region are observed for nodular sclerosis Hodgkin lymphoma (rs9269081, HLA-DPB1*03:01, Val86 in HLA-DRB1) and mixed cellularity Hodgkin lymphoma (rs1633096, rs13196329, Val86 in HLA-DRB1). 29196614 2017
Entrez Id: 3123
Gene Symbol: HLA-DRB1
HLA-DRB1 		0.010 GeneticVariation disease BEFREE Additionally, independent loci within the HLA region are observed for nodular sclerosis Hodgkin lymphoma (rs9269081, HLA-DPB1*03:01, Val86 in HLA-DRB1) and mixed cellularity Hodgkin lymphoma (rs1633096, rs13196329, Val86 in HLA-DRB1). 29196614 2017
Entrez Id: 347734
Gene Symbol: SLC35B2
SLC35B2 		0.010 Biomarker disease BEFREE A psu dic(17;2)(p11.2;p21), leading to p53 deletion, was observed in a patient who developed a mixed cellularity Hodgkin's disease coexisting with the CLL/SLL in the same lymph node. 14703693 2003